美国急性缺血性卒中患者临床试验内与试验外机械取栓的比较
基于2013至2015年全国住院患者样本,比较急性缺血性卒中患者临床试验内与试验外机械取栓的特征和住院结局。23 375例取栓患者中430例(1.8%)在临床试验内完成。调整年龄、性别和医院教学状态后,试验内取栓者住院死亡率更低(OR 0.14;95%CI 0.03至0.71;P<.001),存活出院者中重度残疾率也更低(OR 0.43;95%CI 0.26至0.71;P<.001)。
要点
- 23 375例机械取栓患者中,仅430例(1.8%)在临床试验内完成。
- 调整混杂后,试验内取栓者住院死亡率低于试验外(OR 0.14;95%CI 0.03至0.71;P<.001)。
- 存活出院者中,试验内取栓者中重度残疾率低于试验外(OR 0.43;95%CI 0.26至0.71;P<.001)。
核心结论
- 作为临床试验一部分进行的机械取栓与较低的住院死亡率和较低的中重度残疾率相关。
研究设计与样本
- 基于2013至2015年全国住院患者样本(Nationwide Inpatient Sample)的队列研究,比较临床试验内与试验外机械取栓的急性缺血性卒中患者,共23 375例,其中430例(1.8%)在临床试验内完成。
主要发现
- 23 375例机械取栓患者中,430例(1.8%)在临床试验内完成。
- 调整年龄、性别和医院教学状态后,试验内取栓者住院死亡率低于试验外(OR 0.14;95%CI 0.03至0.71;P<.001)。
- 存活出院者中,试验内取栓者中重度残疾率低于试验外(OR 0.43;95%CI 0.26至0.71;P<.001)。
- 两组取栓后脑出血或蛛网膜下腔出血的比值无差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A better understanding of differences in outcomes of mechanical thrombectomy performed within and outside clinical trials will assist in optimal implementation of the procedure for acute ischemic stroke patients in general practice. OBJECTIVE: To identify differences in demographic and clinical characteristics and outcomes related to mechanical thrombectomy in patients treated within clinical trials and those treated outside clinical trials in a large national cohort. METHODS: We compared the patient characteristics and associated in-hospital outcomes of mechanical thrombectomy in acute ischemic stroke patients performed within and outside clinical trials using the Nationwide Inpatient Sample from 2013 to 2015. We analyzed in-hospital mortality (primary outcome) and moderate to severe disability (secondary outcome) based on discharge disposition after adjusting for potential confounders. RESULTS: Of 23 375 patients who underwent mechanical thrombectomy, 430 (1.8%) underwent the procedure as part of a clinical trial. After adjusting for age, gender, and the teaching status of the hospital, patients treated within a clinical trial had lower rates of in-hospital mortality (odds ratio [OR] 0.14; 95% CI .03 to .71; P < .001). Among patients discharged alive, the rate of moderate to severe disability (OR .43; 95% CI .26 to .71; P < .001) was lower among those patients treated within a clinical trial. There was no difference in odds of post-thrombectomy intracerebral or subarachnoid hemorrhage between the two groups. CONCLUSION: Mechanical thrombectomy performed as part of clinical trials was associated with lower rates of in-hospital mortality and lower rates of moderate to severe disability compared with those performed outside clinical trials.
引用
- Qureshi AI, Singh B, Huang W, et al. Mechanical Thrombectomy in Acute Ischemic Stroke Patients Performed Within and Outside Clinical Trials in the United States. Neurosurgery. 2020. PMID: 31670379. doi:10.1093/neuros/nyz359
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。